03 · What You Need to Know
Children can be vulnerable to both research risk and research exclusion
Why children receive additional research protections
Children may not have the same legal authority or developmental capacity as adults to make research decisions independently. Their understanding of abstract risks, future consequences, probability, voluntariness, and the distinction between research and ordinary care can vary substantially with age and development.
They may also be especially susceptible to influence from parents, teachers, clinicians, researchers, or other adults in positions of authority.
These considerations help explain why regulatory frameworks such as HHS Subpart D impose protections beyond those ordinarily required for competent adults, including parental or guardian permission and provisions for child assent when appropriate.
But exclusion also has consequences
Keeping children out of research avoids certain immediate research risks, but it can create another problem: decisions affecting children may have to rely on evidence that was not actually generated in children.
This concern is particularly clear in health research. The National Institutes of Health states in its inclusion policy that children must be included in NIH-conducted or supported human-subjects research unless there are scientific or ethical reasons not to include them. NIH's policy reflects the concern that excluding children without adequate justification can leave important gaps in knowledge about prevention, diagnosis, and treatment in pediatric populations.
The principle extends beyond medicine. Questions concerning children's learning, development, digital behavior, social relationships, mental health, communication, and educational experiences may sometimes require evidence obtained from children themselves rather than extrapolated entirely from adults.
Protection from research
Excluding children from a study because participation would expose them to unjustifiable risk or because their inclusion is scientifically unnecessary.
Protection in research
Allowing ethically justified participation while modifying procedures, communication, monitoring, consent processes, and other safeguards to address children's particular vulnerabilities.
The first question is whether involving children is scientifically necessary
Children should not be recruited merely because they are conveniently available or because the investigator wants a broader sample. Researchers should be able to explain what knowledge requires or justifies pediatric participation.
Sometimes the answer is straightforward. A study of early language development cannot simply substitute adults. A pediatric dosing study may need children because drug metabolism, appropriate dosage, safety, or effectiveness may differ from adults. Research on children's experiences in school may require children's perspectives rather than relying exclusively on parents or teachers.
In other studies, including children may add little scientific value while introducing avoidable complexity or risk. Ethical inclusion is not the same as maximum inclusion.
Ask whether adults could answer the question first
One useful consideration is whether the research question can be answered adequately using adults who can provide their own informed consent.
For research involving more than minimal risk without a prospect of direct benefit, HHS regulations impose particular limits on when research with children can be approved. The regulatory structure reflects a broader ethical concern: children should not bear research burdens that are unnecessary to answer the scientific question.
But “we could study adults” is not always decisive. If the phenomenon, intervention, developmental process, or outcome differs meaningfully in children, adult evidence may not answer the pediatric question.
Risk should be reduced before exclusion is considered
A study that is initially inappropriate for children may sometimes become ethically acceptable after redesign.
Researchers might reduce the number of invasive procedures, use existing clinical samples rather than collect additional specimens, shorten interviews, replace an invasive measure with a validated noninvasive alternative, reduce the frequency of study visits, conduct procedures in familiar settings, or separate optional components from those scientifically essential to the protocol.
This approach asks a better question than “Are children too vulnerable for this study?” It asks, “Which features of this study create avoidable burden or risk, and can we change them without destroying the scientific value of the research?”
Minimal risk does not mean no risk
Under HHS regulations, minimal risk means that the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during routine physical or psychological examinations or tests.
Research involving children that presents no greater than minimal risk may be approvable under 45 CFR 46.404 when adequate provisions are made for soliciting child assent and parental or guardian permission as required by 46.408.
The classification should not become a casual label. Investigators and IRBs need to evaluate the actual procedures, population, setting, and foreseeable harms.
Potential direct benefit changes the risk analysis
HHS regulations also permit certain research involving greater than minimal risk when the intervention or procedure presents the prospect of direct benefit to the individual child, the risk is justified by that anticipated benefit, and the relationship of anticipated benefit to risk is at least as favorable as available alternatives.
This does not mean that any study offering possible benefit becomes acceptable. The IRB must make the required findings under the applicable regulatory category.
It does, however, show why a blanket rule excluding children from all research involving more than minimal risk would be too crude. Some pediatric research may be ethically permissible precisely because the child may directly benefit from an intervention that needs to be studied.
Research without direct benefit receives tighter limits
Under 45 CFR 46.406, certain research involving a minor increase over minimal risk and no prospect of direct benefit may be approvable when the intervention or procedure presents experiences reasonably commensurate with those inherent in the children's actual or expected medical, dental, psychological, social, or educational situations and is likely to yield generalizable knowledge of vital importance about the children's disorder or condition.
The requirements are deliberately more restrictive because the child is being exposed to research risk without an anticipated direct benefit from the intervention or procedure.
Researchers should therefore distinguish carefully between benefits to the individual participant and the societal or scientific value of producing useful knowledge. A study can be scientifically valuable without directly benefiting the child who participates.
Scientific knowledge is not itself a direct benefit to the participant
Statements such as “this research may help children in the future” describe potential societal or scientific benefit. They should not be presented as though they were a direct clinical, educational, or psychological benefit to the participant.
This distinction matters when determining which regulatory risk category applies and when explaining research to families.
Watch Out
Do not justify greater research risk by saying only that “the study will benefit children.” Knowledge that may help future children is valuable, but it is not the same as a prospect of direct benefit to the child currently participating.
Some pediatric research requires additional federal review
HHS regulations provide a pathway under 45 CFR 46.407 for research that is not otherwise approvable under the preceding pediatric categories but presents a reasonable opportunity to further understanding, prevention, or alleviation of a serious problem affecting children's health or welfare.
Such research requires additional review beyond an ordinary IRB approval, including consultation with experts and an opportunity for public review and comment before the Secretary of HHS can make the required determinations.
The existence of this pathway reinforces an important point: difficult pediatric research is not handled by pretending that vulnerability does not exist. It is handled by increasing scrutiny when the scientific and social importance may justify further consideration.
Children should have an appropriate voice in participation
Protection is not limited to what adults decide for children. When children are capable of assent, giving them an appropriate role in the participation decision is itself a safeguard.
Researchers should consider whether children can meaningfully assent and communicate information at a level they can understand. Assent recognizes that legal inability to provide adult consent does not make children's preferences ethically irrelevant.
Likewise, researchers should take seriously a capable child's refusal of participation when assent is required rather than assuming parental permission resolves every disagreement.
Parental permission should protect children without unnecessarily blocking participation
Parental or guardian permission is another central safeguard, but it should not be treated mechanically. Researchers need to explain the study adequately to parents, avoid coercion or undue influence, and give them a meaningful opportunity to decide.
In unusual populations or circumstances, however, parental permission itself may not function as a reasonable protection. HHS regulations provide pathways through which an IRB can waive parental permission under specified conditions.
This can become particularly important in sensitive adolescent research where parental involvement may create risk. Removing parental permission should involve careful substitution of other protections rather than simply lowering the ethical threshold for participation.
Inclusion also means avoiding arbitrary age exclusions
A protocol may exclude participants below 18 simply because adult recruitment is administratively easier. Sometimes that restriction is scientifically or ethically defensible. Sometimes it is merely inherited from previous studies.
Researchers should ask what the age restriction actually accomplishes. Does the intervention lack pediatric safety information? Is the measure invalid for children? Would developmental differences make interpretation impossible? Does applicable law create a genuine obstacle? Or does the age cutoff simply avoid designing an assent and parental-permission process?
Administrative convenience is a weak scientific justification for excluding a population to whom the research question meaningfully applies.
Inclusion does not require treating all children as one population
Children span substantial developmental differences. A study appropriate for a 16-year-old may be inappropriate for a six-year-old even though both are legally children.
Researchers can use scientifically justified age ranges, developmental criteria, staged enrollment, age-adapted procedures, or different assent approaches. The objective is not to eliminate every eligibility restriction but to make restrictions defensible in relation to the question, risks, and participants.
Equitable inclusion includes who within childhood gets represented
A study can technically include children while still excluding important groups of children through its design. Recruitment limited to families with reliable transportation, fluent speakers of one language, children without disabilities, or families able to attend appointments during working hours may produce a narrow pediatric sample.
Some exclusions may be necessary for scientific or safety reasons. Others may reflect modifiable features of the protocol.
Researchers should examine whether eligibility criteria, recruitment methods, communication formats, locations, scheduling, and participation burdens systematically exclude children without sufficient justification.
Protection should be proportionate rather than paternalistic
Additional safeguards are appropriate because children can face genuine vulnerabilities. Yet protection becomes ethically questionable when it assumes that children should never encounter any research burden, can contribute nothing to decisions, or should be excluded whenever accommodating them requires additional work.
A proportionate approach links the protection to the actual vulnerability. Younger children may need simpler explanations. A painful procedure may require stronger scientific justification and pain-reduction strategies. A sensitive interview may require stronger privacy protections. A child with communication differences may need an adapted assent method.
The safeguard should solve the problem rather than merely remove the participant.
